Literature DB >> 22935793

Regulatory watch: pioneering gene therapy on brink of approval.

Alexandra Flemming.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22935793     DOI: 10.1038/nrd3835

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  Regulatory evaluation of Glybera in Europe - two committees, one mission.

Authors:  Daniela Melchiorri; Luca Pani; Paolo Gasparini; Giulio Cossu; Janis Ancans; John Joseph Borg; Catherine Drai; Piotr Fiedor; Egbert Flory; Ian Hudson; Hubert G Leufkens; Jan Müller-Berghaus; Gopalan Narayanan; Brigitte Neugebauer; Juris Pokrotnieks; Jean-Louis Robert; Tomas Salmonson; Christian K Schneider
Journal:  Nat Rev Drug Discov       Date:  2013-08-19       Impact factor: 84.694

Review 2.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development.

Authors:  Hui Ling; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

Review 3.  Non-coding RNAs in cancer diagnosis and therapy.

Authors:  Mahmood Rasool; Arif Malik; Sara Zahid; Muhammad Abdul Basit Ashraf; Mahmood Husain Qazi; Muhammad Asif; Ahmad Zaheer; Muhammad Arshad; Amir Raza; Mohammad Sarwar Jamal
Journal:  Noncoding RNA Res       Date:  2016-11-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.